000 01544 a2200505 4500
005 20250517205957.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-018-4170-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAn, Xin
245 0 0 _aThe prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
_h[electronic resource]
260 _bBMC cancer
_c03 2018
300 _a331 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aDNA Topoisomerases, Type II
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aNeoplasm Staging
650 0 4 _aPoly-ADP-Ribose Binding Proteins
_xgenetics
650 0 4 _aPrognosis
650 0 4 _aRecurrence
700 1 _aXu, Fei
700 1 _aLuo, Rongzhen
700 1 _aZheng, Qiufan
700 1 _aLu, Jiabin
700 1 _aYang, Yanhua
700 1 _aQin, Tao
700 1 _aYuan, Zhongyu
700 1 _aShi, Yanxia
700 1 _aJiang, Wenqi
700 1 _aWang, Shusen
773 0 _tBMC cancer
_gvol. 18
_gno. 1
_gp. 331
856 4 0 _uhttps://doi.org/10.1186/s12885-018-4170-7
_zAvailable from publisher's website
999 _c28224435
_d28224435